Forskning
Udskriv Udskriv
Switch language
Rigshospitalet - en del af Københavns Universitetshospital
Udgivet

Using an electronic platform interactively to improve treatment outcome in patients with rheumatoid arthritis: new developments from the DANBIO registry

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Ultrasonography in gout: utility in diagnosis and monitoring

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Update on imaging in rheumatic diseases

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. ABILITY OF MAGNETIC RESONANCE IMAGING TO PREDICT REMISSION AND RELAPSE IN PERIPHERAL SPONDYLOARTHRITIS

    Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

Vis graf over relationer

OBJECTIVES: Electronic platforms have been developed to help the clinician monitor disease activity in rheumatoid arthritis (RA) to support at treat-to-target strategy. We present an initiative to interactively improve disease control in patients with rheumatoid arthritis.

METHODS: In patients who presented with one or more swollen joints AND moderate/high disease activity (i.e. either CDAI≥10.1 and/or DAS-28CRP>3.2, which is automatically calculated in the DANBIO registry), a red alert was shown, which activated a pop-up: "This patient has at least one swollen joint AND either CDAI≥ 10.1 or DAS28CRP>3.2. Which action do you as a physician take today: □ Intensify treatment, □ Treatment intensification is not possible currently/awaiting results of additional investigations, □ No further treatment intensification is possible, □ The patient does not want to intensify treatment, □ Other decisions taken" RESULTS: Of 21,056 patients with RA, 40% fulfilled the criteria for getting the alert message. The pop-up was activated and completed by the physician in 65% of those (5,428 patients). Treatment was intensified in 67%. In 2% of patients, no additional treatment intensification was possible, and 8% of the patients objected to intensification.

CONCLUSIONS: In >8,000 RA patients who presented with objective signs of active disease in routine care, an interactive feature of the DANBIO registry was introduced, which prompted the physician to take action and consider treatment intensification. In two-thirds of the cases, the treating physician reported that treatment was intensified.

OriginalsprogEngelsk
TidsskriftClinical and Experimental Rheumatology
Vol/bind34
Udgave nummer5 Suppl 101
Sider (fra-til)S75-8
Antal sider4
ISSN0392-856X
StatusUdgivet - 21 okt. 2016

ID: 49686656